ArticleScientific reports2026
Solidago canadensis extract fractionation, phytochemical identification, and nematicidal/nematistatic activity against Meloidogyne incognita.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of eco-friendly pest management strategies is crucial for sustainable agriculture. In this study, we investigated the bioactivity of Solidago canadensis leaf extract against Meloidogyne incognita juveniles (J2). In vitro assays showed that aqueous extracts exhibited greater nematistatic (immobilizing) activity than less polar solvent extracts. Fractionation of the aqueous decoction extract using column chromatography yielded 11 fractions (F), which were evaluated at 100, 200, and 300 mg L
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.